✦ LIBER ✦

599 ORAL Improved activity with irinotecan, oxaliplatin and infusional 5-FU/LV (FOLFOXIRI) compared with FOLFIRI in metastatic colorectal cancer (MCRC): results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6081 Bevacizumab (BV) in combination wit

✍ Masi, G.; Salvatore, L.; Fornaro, L.; Vasile, E.; Baldi, G.G.; Stasi, I.; Ciarlo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

3063 POSTER Capecitabine (C), in combina

✍ S. Bursi; G. Masi; F. Loupakis; A. Antonuzzo; S. Chiara; E. Pfanner; I. Petrini; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

6096 POSTER FOLFOXIRI (Irinotecan, Oxali

✍ Fornaro, L.; Loupakis, F.; Lonardi, S.; Masi, G.; Salvatore, L.; Cremolini, C.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB